Spots Global Cancer Trial Database for shr6508;placebo
Every month we try and update this database with for shr6508;placebo cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial of SHR6508 in Secondary Hyperparathyroidism | NCT05221008 | Secondary Hyper... | SHR6508;Placebo SHR6508;Placebo SHR6508;Placebo SHR6508;Placebo | 18 Years - 70 Years | Shanghai Hengrui Pharmaceutical Co., Ltd. |